Xie L, Li J, Chen X, Yin M, Huang W, Luo M
Arch Virol. 2025; 170(3):56.
PMID: 39948291
DOI: 10.1007/s00705-025-06247-z.
Rahmouni M, Le Clerc S, Spadoni J, Labib T, Tison M, Medina-Santos R
BMC Immunol. 2025; 26(1):1.
PMID: 39762745
PMC: 11702083.
DOI: 10.1186/s12865-024-00680-6.
Phan T, Conway J, Pagane N, Kreig J, Sambaturu N, Iyaniwura S
PLoS Pathog. 2024; 20(7):e1012236.
PMID: 39074163
PMC: 11309407.
DOI: 10.1371/journal.ppat.1012236.
Mainou E, Berendam S, Obregon-Perko V, Uffman E, Phan C, Shaw G
bioRxiv. 2024; .
PMID: 38826467
PMC: 11142125.
DOI: 10.1101/2024.05.21.595130.
Phan T, Conway J, Pagane N, Kreig J, Sambaturu N, Iyaniwura S
bioRxiv. 2024; .
PMID: 38746144
PMC: 11092759.
DOI: 10.1101/2024.05.03.592318.
Complete Rescue of HTLV-1 Infectivity by Depletion of Monocytes Together with NK and CD8 T Cells.
Gutowska A, Sarkis S, Rahman M, Goldfarbmuren K, Moles R, Bissa M
Pathogens. 2024; 13(4).
PMID: 38668247
PMC: 11054408.
DOI: 10.3390/pathogens13040292.
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques.
Tuyishime M, Spreng R, Hueber B, Nohara J, Goodman D, Chan C
Front Immunol. 2023; 14:1260377.
PMID: 38124734
PMC: 10732150.
DOI: 10.3389/fimmu.2023.1260377.
Rev-Rev Response Element Activity Selection Bias at the Human Immunodeficiency Virus Transmission Bottleneck.
Jackson P, Holsey J, Turse L, Hammarskjold M, Rekosh D
Open Forum Infect Dis. 2023; 10(10):ofad486.
PMID: 37854107
PMC: 10580148.
DOI: 10.1093/ofid/ofad486.
Targeted plasma proteomics identifies MICA and IL1R1 proteins associated with HIV-1 reservoir size.
Blaauw M, Dos Santos J, Vadaq N, Trypsteen W, van der Heijden W, Groenendijk A
iScience. 2023; 26(4):106486.
PMID: 37091231
PMC: 10113782.
DOI: 10.1016/j.isci.2023.106486.
CD3CD56 and CD3CD56 lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and C.
de Almeida S, Beltrame M, Tang B, Rotta I, Justus J, Schluga Y
J Neuroimmunol. 2023; 377:578067.
PMID: 36965365
PMC: 10817703.
DOI: 10.1016/j.jneuroim.2023.578067.
Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection.
Abeynaike S, Huynh T, Mehmood A, Kim T, Frank K, Gao K
Viruses. 2023; 15(2).
PMID: 36851579
PMC: 9960100.
DOI: 10.3390/v15020365.
Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko R, Mailliard R
J Leukoc Biol. 2023; 113(2):109-138.
PMID: 36822173
PMC: 10043732.
DOI: 10.1093/jleuko/qiac007.
Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events.
Woolley G, Mosher M, Kroll K, Jones R, Hueber B, Sugawara S
J Virol. 2022; 97(1):e0151922.
PMID: 36511699
PMC: 9888193.
DOI: 10.1128/jvi.01519-22.
Bispecific antibody-derived molecules to target persistent HIV infection.
Nordstrom J, Ferrari G, Margolis D
J Virus Erad. 2022; 8(3):100083.
PMID: 36111287
PMC: 9468498.
DOI: 10.1016/j.jve.2022.100083.
Improved induced innate immune response after cART initiation in people with HIV.
Hove-Skovsgaard M, Moller D, Hald A, Gerstoft J, Lundgren J, Ostrowski S
Front Immunol. 2022; 13:974767.
PMID: 36059528
PMC: 9428745.
DOI: 10.3389/fimmu.2022.974767.
Elevated KIR expression and diminished intensity of CD7 on NK cell subsets among treatment naïve HIV infected Ethiopians.
Andualem H, Lemma M, Keflie A, Workeneh M, Ayelign B, Tassachew Y
Sci Rep. 2022; 12(1):14747.
PMID: 36042218
PMC: 9427747.
DOI: 10.1038/s41598-022-18413-3.
The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
Macedo A, Levinger C, Nguyen B, Richard J, Gupta M, Cruz C
J Virol. 2022; 96(15):e0037222.
PMID: 35867565
PMC: 9364794.
DOI: 10.1128/jvi.00372-22.
Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance.
Duan S, Liu S
Front Immunol. 2022; 13:842746.
PMID: 35371060
PMC: 8967654.
DOI: 10.3389/fimmu.2022.842746.
The Role of Innate Immunity in Natural Elite Controllers of HIV-1 Infection.
Shi Y, Su J, Chen R, Wei W, Yuan Z, Chen X
Front Immunol. 2022; 13:780922.
PMID: 35211115
PMC: 8861487.
DOI: 10.3389/fimmu.2022.780922.
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients.
Flores-Gonzalez J, Ramon-Luing L, Ocana-Guzman R, Buendia-Roldan I, Islas-Munoz B, Volkow-Fernandez P
Cancers (Basel). 2022; 14(2).
PMID: 35053573
PMC: 8773484.
DOI: 10.3390/cancers14020412.